Papers
1
Total Citations
2
H-Index
1
About
Dr. Siwei Ding is a clinician-researcher specializing in hereditary renal cancer syndromes, with a particular focus on HLRCC (hereditary leiomyomatosis and renal cell carcinoma)-associated renal cell carcinoma. Their landmark case report, "Going through pregnancy safely after twice partial nephrectomy for bilateral kidneys with HLRCC-associated RCC," represents the first documented instance of a patient with bilateral HLRCC-associated RCC successfully navigating pregnancy following two partial nephrectomies. This work addresses a critical gap in the literature regarding reproductive outcomes in patients with this rare autosomal dominant genetic condition caused by germline FH gene mutations. Despite being published in 2022 and accumulating 2 citations, the study's significance lies in its pioneering clinical guidance for managing pregnancy in HLRCC patients—a population where fertility and obstetric considerations were previously unaddressed. Dr. Ding's contribution bridges oncology and reproductive medicine, offering hope and evidence-based strategies for affected individuals. This case report underscores their commitment to advancing care for rare hereditary cancers and improving quality of life beyond oncological outcomes.
Research Focus
Key Achievements
Top Papers
- 1